nad has been researched along with 2,6-xylidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baillie, TA; Berthon-Cédille, L; Bishop, FE; Descombe, JJ; Kerr, BM; Lepage, F; Levy, RH; Martin, SW; Moor, M; Moore, M; Picard, M; Rashed, M; Sheffels, P; Slatter, JG | 1 |
1 other study(ies) available for nad and 2,6-xylidine
| Article | Year |
|---|---|
Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans.
Topics: Aniline Compounds; Animals; Anticonvulsants; Biological Availability; Humans; Isoxazoles; Male; Microsomes, Liver; NAD; Rats; Rats, Sprague-Dawley | 1997 |